Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers

被引:32
作者
Bian, Yuemin [1 ,2 ,3 ,4 ]
Jing, Yankang [1 ,2 ,3 ,4 ]
Wang, Lirong [1 ,2 ,3 ,4 ]
Ma, Shifan [1 ,2 ,3 ,4 ]
Jun, Jaden Jungho [1 ,2 ,3 ,4 ]
Xie, Xiang-Qun [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Pharm, Computat Chem Genom Screening Ctr, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, NIH, Natl Ctr Excellence Computat Drug Abuse Res, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Drug Discovery Inst, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[5] Univ Pittsburgh, Sch Med, Dept Computat Biol, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[6] Univ Pittsburgh, Sch Med, Dept Biol Struct, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
关键词
cannabinoid receptor; allosteric regulation; machine learning; deep neural network; drug design; INVERSE AGONISTS; NEURAL-NETWORKS; DISCOVERY; CB1; MODULATORS; LIGAND; IDENTIFICATION; OPTIMIZATION; DERIVATIVES; ANTAGONISTS;
D O I
10.1021/acs.molpharmaceut.9b00182
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Designing highly selective compounds to protein subtypes and developing allosteric modulators targeting them are critical considerations to both drug discovery and mechanism studies for cannabinoid receptors. It is challenging but in demand to have classifiers to identify active ligands from inactive or random compounds and distinguish allosteric modulators from orthosteric ligands. In this study, supervised machine learning classifiers were built for two subtypes of cannabinoid receptors, CB1 and CB2. Three types of features, including molecular descriptors, MACCS fingerprints, and ECFP6 fingerprints, were calculated to evaluate the compound sets from diverse aspects. Deep neural networks, as well as conventional machine learning algorithms including support vector machine, naive Bayes, logistic regression, and ensemble learning, were applied. Their performances on the classification with different types of features were compared and discussed. According to the receiver operating characteristic curves and the calculated metrics, the advantages and drawbacks of each algorithm were investigated. The feature ranking was followed to help extract useful knowledge about critical molecular properties, substructural keys, and circular fingerprints. The extracted features will then facilitate the research on cannabinoid receptors by providing guidance on preferred properties for compound modification and novel scaffold design. Besides using conventional molecular docking studies for compound virtual screening, machine-learning-based decision-making models provide alternative options. This study can be of value to the application of machine learning in the area of drug discovery and compound development.
引用
收藏
页码:2605 / 2615
页数:11
相关论文
共 52 条
[1]  
Aghazadeh Tabrizi M., 2016, CHEM REV, V116, P519, DOI DOI 10.1021/acs.chemrev.5b00411
[2]  
Berthold M.R., 2009, SIGKDD Explor. Newsl, V11, P26, DOI DOI 10.1145/1656274.1656280
[3]   Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation [J].
Bian, Yue-min ;
He, Xi-bing ;
Jing, Yan-kang ;
Wang, Li-rong ;
Wang, Jun-mei ;
Xie, Xiang-Qun .
ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) :374-386
[4]   Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications [J].
Bian, Yuemin ;
Xie, Xiang-Qun .
AAPS JOURNAL, 2018, 20 (03)
[5]   Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5 [J].
Bian, Yuemin ;
Feng, Zhiwei ;
Yang, Peng ;
Xie, Xiang-Qun .
AAPS JOURNAL, 2017, 19 (04) :1235-1248
[6]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[7]   Novel cannabinoid receptors [J].
Brown, A. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) :567-575
[8]  
Campbell C, 2003, SIGKDD EXPLOR NEWSL, V2, P1, DOI [10.1145/380995.380999, DOI 10.1145/380995.380999]
[9]   Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders [J].
Conn, P. Jeffrey ;
Christopoulos, Arthur ;
Lindsley, Craig W. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :41-54
[10]   SUBSTRUCTURAL ANALYSIS - NOVEL APPROACH TO PROBLEM OF DRUG DESIGN [J].
CRAMER, RD ;
REDL, G ;
BERKOFF, CE .
JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (05) :533-535